Participation of miR-200 in pulmonary fibrosis - Wikidata - awgldk - TriplyDB

Participation of miR-200 in pulmonary fibrosis

Participation of miR-200 in pulmonary fibrosis

http://www.wikidata.org/entity/Q42157000

about

Targeting MicroRNA Function in Respiratory Diseases: Mini-Review microRNA regulation of peritoneal cavity homeostasis in peritoneal dialysis MicroRNAs in respiratory disease. A clinician's overview EMT and interstitial lung disease: a mysterious relationship Beyond the genome: epigenetic mechanisms in lung remodeling Novel insights into miRNA in lung and heart inflammatory diseases MicroRNAs in idiopathic pulmonary fibrosis: involvement in pathogenesis and potential use in diagnosis and therapeutics Function and Regulation of MicroRNAs and Their Potential as Biomarkers in Paediatric Liver Disease The code of non-coding RNAs in lung fibrosis MiRNAs in kidney transplantation: potential role as new biomarkers.The peripheral blood proteome signature of idiopathic pulmonary fibrosis is distinct from normal and is associated with novel immunological processes Integrated analyses identify the involvement of microRNA-26a in epithelial-mesenchymal transition during idiopathic pulmonary fibrosis.The antifibrotic effects and mechanisms of microRNA-26a action in idiopathic pulmonary fibrosis Improving biocuration of microRNAs in diseases: a case study in idiopathic pulmonary fibrosis.Regulation of myofibroblast differentiation by miR-424 during epithelial-to-mesenchymal transition.Characterizing dynamic regulatory programs in mouse lung development and their potential association with tumourigenesis via miRNA-TF-mRNA circuits.Single nucleotide polymorphisms of cathepsin S and the risks of asthma attack induced by acaroid mites A microrna screen to identify regulators of peritoneal fibrosis in a rat model of peritoneal dialysis.miR-144 regulates transforming growth factor-β1 iduced hepatic stellate cell activation in human fibrotic liver Idiopathic pulmonary fibrosis and cancer: do they really look similar?miR-130b-3p Modulates Epithelial-Mesenchymal Crosstalk in Lung Fibrosis by Targeting IGF-1 MicroRNA-144 dysregulates the transforming growth factor-β signaling cascade and contributes to the development of bronchiolitis obliterans syndrome after human lung transplantation Potential application of miRNAs as diagnostic and therapeutic tools in chronic pancreatitis.The Anti-fibrotic Effects and Mechanisms of MicroRNA-486-5p in Pulmonary Fibrosis MiR-338* targeting smoothened to inhibit pulmonary fibrosis by epithelial-mesenchymal transition.MicroRNAs and fibrosis miR-200c is aberrantly expressed in leiomyomas in an ethnic-dependent manner and targets ZEBs, VEGFA, TIMP2, and FBLN5.Alteration of Aging-Dependent MicroRNAs in Idiopathic Pulmonary Fibrosis.MicroRNAs as potential targets for progressive pulmonary fibrosis Glycolytic Reprogramming in Myofibroblast Differentiation and Lung Fibrosis.miR-145 regulates myofibroblast differentiation and lung fibrosis.MicroRNA regulation of nonmuscle myosin light chain kinase expression in human lung endothelium.Potential role of human-specific genes, human-specific microRNAs and human-specific non-coding regulatory RNAs in the pathogenesis of systemic sclerosis and Sjögren's syndrome.MicroRNA and nephropathy: emerging concepts.Serum extracellular vesicular miR-21-5p is a predictor of the prognosis in idiopathic pulmonary fibrosis.RNAi Therapeutic Platforms for Lung Diseases.Changes in expression of four molecular marker proteins and one microRNA in mesothelial cells of the peritoneal dialysate effluent fluid of peritoneal dialysis patients Mechanistic links between aging and lung fibrosis.Role of MicroRNAs in lung disease.The role of miR-497-5p in myofibroblast differentiation of LR-MSCs and pulmonary fibrogenesis.

P2860

Q26766476-8E4830B8-530C-4F97-AB03-11CE08C3A72C Q26779972-2A9F3891-F96D-493A-8131-AE1C9B890876 Q26823456-8481EF36-5304-401E-A16C-550CDA84D8C0 Q26824760-322F8151-6F7C-4C3E-8319-190208D59854 Q27021767-6CA33F32-8C50-4678-A727-EF48F5DB6770 Q27026348-F6A304D3-76AC-4203-8414-85848333A105 Q28068338-079AE958-AFA5-4B0F-821C-A3CABD45A66B Q28073703-31FB909E-AE2B-436D-A645-11ABC60C9C86 Q28386827-E7E2C55D-40D6-4ACF-A14B-469D4E01F894 Q30456341-F7FAAEDA-D79C-424B-9E5A-7BCFB44ACAF1 Q33601748-2E65370A-E5FC-47B1-9D5C-7599DB78D521 Q33720132-B3F0FF95-64DE-4CCA-A57F-B3CE10CAFEA9 Q33724231-B754FEAA-2D7D-4234-8320-B7A36284623A Q33787495-2ED1FB51-D952-458E-943E-134B867A5D1E Q34979698-76468A9A-2ED6-4A75-A1D7-0BFD5D4A0C83 Q35101881-936F2525-848F-493F-BCC7-24B5C9EFF061 Q35173790-04586C50-6692-4C78-BFEC-7D446B2AF192 Q35605375-24D28585-E53E-496E-834F-8D2824998123 Q35741106-D89DD7F5-AD5B-4929-AC8E-B53749E410A1 Q35785589-A32FFE79-73C1-4528-9CC3-C9E211354094 Q35949070-F83DBEDB-DD7C-4B5E-895B-078B667FB9C9 Q35952077-13273D87-11E9-4F80-9B6A-B52F81AA15CF Q36057439-D4668C90-7E95-4DA9-B3FA-F5A55E7E6FEF Q36059848-209B6541-5867-42E3-89AC-7D5E7851685E Q36099932-C9BEE26E-F764-4216-9A5C-C388C829709F Q36103009-C0108B3B-E35E-4E82-A5D5-A082E08CBA51 Q36108865-EF2105FA-0031-4D35-9C52-A3BFBAF246FE Q36190899-9F3897CE-50EB-4C5C-B63E-76C8D1C82B3A Q36249425-776A657C-7D30-4005-8D8B-869ACA835D01 Q36516888-06CE641A-74E3-46F9-9ECB-0514251D29E5 Q36860296-B6B71D95-E622-471E-AF58-C1781D42527D Q37056472-EDB9D0C9-77A2-4CD7-BD24-C2A538D69FF2 Q37165647-640B4451-0AA0-464C-8F2D-71887084AD14 Q37221074-2F43B4CF-13BE-413B-A641-8B19BBD60A92 Q37233229-5EE93B2A-9C97-4F77-9206-7B44BF7D9EBC Q37277373-FA47FD52-40D7-4C6A-9490-1837384C4606 Q37288876-036654B5-DC8E-4F59-9237-4285AC6F4EED Q37366137-95CB8421-344F-47CE-B634-52849E454507 Q37374960-D0AA6D16-1316-4EC1-89E4-EE8DBB20D22D Q37591427-6ABD0E30-97C4-4432-BA02-5605BB40C012

P2860

Participation of miR-200 in pulmonary fibrosis

http://www.wikidata.org/entity/Q42157000

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年学术文章

@wuu

2011年学术文章

@zh-cn

2011年学术文章

@zh-hans

2011年学术文章

@zh-my

2011年学术文章

@zh-sg

2011年學術文章

@yue

2011年學術文章

@zh

2011年學術文章

@zh-hant

name

Participation of miR-200 in pulmonary fibrosis

@en

Participation of miR-200 in pulmonary fibrosis

@nl

type

label

Participation of miR-200 in pulmonary fibrosis

@en

Participation of miR-200 in pulmonary fibrosis

@nl

prefLabel

Participation of miR-200 in pulmonary fibrosis

@en

Participation of miR-200 in pulmonary fibrosis

@nl

P1433

Q42157000-20B0D2FE-DC5C-4F74-A93B-9516F8D85861

P1476

Q42157000-AEEA93F8-4430-486D-8FDA-AA7ABFAFD574

P2093

Q42157000-1012E101-9E38-431F-87C4-1606F19D167E

Q42157000-15907719-B6A0-4B2C-B330-630FD1704FDE

Q42157000-15DF72A0-4224-43F9-BD47-84299F6A0D6A

Q42157000-20E60F1A-9C50-455E-85AE-DDF8221E4D30

Q42157000-32B7D019-649C-4D13-AC6C-C208F24371C2

Q42157000-4C64DE8C-5F67-4855-9466-103B8AD6F02D

Q42157000-DD4006AE-875A-4005-87EB-4DBC055E6A02

Q42157000-E03B8636-97E5-4557-BA5B-21C9656A361B

Q42157000-E8739C4D-6394-4308-8258-79606269AF9E

P2860

Q42157000-001522AD-2515-4AA6-BE1B-50B1D2AA1C4F

Q42157000-04D41A34-5B3C-4529-A67C-F1D0AC28FD27

Q42157000-07FCE356-E122-49B4-92A5-67FE7B8E3E0C

Q42157000-0E6F337F-ED95-4F97-8457-6A7D0A66330B

Q42157000-0F33EAE4-580D-4E12-AC23-710B6AAB10A8

Q42157000-0F50BD95-7BB2-46AC-B6A5-B29492EDC559

Q42157000-151757D9-0E81-458F-9CCA-10D1D0C5403D

Q42157000-1C7BB491-88B8-4570-80CE-1044B12C5A43

Q42157000-1E6DF94C-F889-43A1-A647-3A808D35FED8

Q42157000-1E96D88F-7544-4E66-80C5-8E6CF35C4489

P304

Q42157000-2203F8E1-B4A3-40BF-9C52-0B57E844E83B

P31

Q42157000-B40783BA-1D62-479C-9751-4A85DF47B3A5

P356

Q42157000-FD176FF3-1FB1-4095-9550-0A0A66C6C033

P407

Q42157000-CE84778F-E2B7-4305-9A89-64FC44110745

P433

Q42157000-2C3CF658-ABAC-46D0-BE71-6A265CCC06DA

P478

Q42157000-341C712D-381E-4514-8233-1405DE6BB379

P577

Q42157000-1F84AF38-A455-4BB8-9A66-4F0F86DCA6E3

P5875

Q42157000-EE59B052-59D9-4553-AE67-CE2FBDB54291

P698

Q42157000-3E6C2D1C-0BEB-4432-B32B-75F03FCD20F4

P921

Q42157000-B3A44A7A-ADB9-4926-9B2E-A6A63C242D98

P932

Q42157000-D93A7703-163C-4A2B-90E0-787DCA50ADA4

P356

J.AJPATH.2011.10.005

P1433

The American Journal of Pathology

P1476

Participation of miR-200 in pulmonary fibrosis

@en

P2093

Andressa de Freitas

http://www.w3.org/2001/XMLSchema#string

Edward Abraham

http://www.w3.org/2001/XMLSchema#string

Gang Liu

http://www.w3.org/2001/XMLSchema#string

Qiang Ding

http://www.w3.org/2001/XMLSchema#string

Sadis Matalon

http://www.w3.org/2001/XMLSchema#string

Sami Banerjee

http://www.w3.org/2001/XMLSchema#string

Shanzhong Yang

http://www.w3.org/2001/XMLSchema#string

Victor J Thannickal

http://www.w3.org/2001/XMLSchema#string

Yan Y Sanders

http://www.w3.org/2001/XMLSchema#string

P2860

GATA3 inhibits breast cancer metastasis through the reversal of epithelial-mesenchymal transition

Inhibition and role of let-7d in idiopathic pulmonary fibrosis

The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2

WNT1-inducible signaling protein-1 mediates pulmonary fibrosis in mice and is upregulated in humans with idiopathic pulmonary fibrosis

The basics of epithelial-mesenchymal transition

TGF-beta1 induces human alveolar epithelial to mesenchymal cell transition (EMT)

Epithelial-mesenchymal transitions in development and disease

The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1

Myofibroblasts and mechano-regulation of connective tissue remodelling

Causes and consequences of microRNA dysregulation in cancer

P304

484-493

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.AJPATH.2011.10.005

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

180

http://www.w3.org/2001/XMLSchema#string

P577

2011-12-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51905646

http://www.w3.org/2001/XMLSchema#string

P698

22189082

http://www.w3.org/2001/XMLSchema#string

P921

pulmonary fibrosis

P932

3349843

http://www.w3.org/2001/XMLSchema#string